Treatment of Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep After High-Dose Oral Benzodiazepines Have Failed
In epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS), high-dose oral benzodiazepines given before sleep are an established first step. When this treatment does not achieve the required clinical or EEG response targets, a structured next-line protocol is indicated.
The first-line approach — high-dose oral benzodiazepines before sleep (oral diazepam or clobazam) — is considered to have failed when neither of the following response criteria has been met:
- Clinical response: improvement in neurocognitive function, seizures, or EEG findings.
- SWI response: at least a 50% reduction in the sleep spike wave index (SWI) on post-treatment EEG compared to pre-treatment.
When benzodiazepines have not achieved these targets, the next protocol involves steroids or immune-modulating therapy. The complete regimen — specifying agents, formulations, and sequence — is available in the full structured protocol.
Agent selection, dosing, and the full clinical algorithm are not shown here — access the complete regimen below.
The same dual response criteria apply to the next-line treatment:
- Clinical response: improvement in neurocognitive function, seizures, or the EEG.
- SWI response: at least 50% reduction in the sleep spike wave index comparing post- and pre-treatment EEGs.
- Steroids have been given in oral and intravenous (IV) formulations, and other immune-modulating agents including ACTH and IVIG have been administered with varying success.
- In our cohort, all but two patients received oral prednisone or prednisolone, whereas the majority of patients in the European study received intravenous, pulse-dose methylprednisolone.
- Study design must account for the fact that steroids are typically prescribed after failure of the first agent.
- The clinical response was defined as clinical improvement in neurocognitive function, seizures, or the EEG after therapy as judged and documented in the medical record by the treating neurologist.
- The SWI response was defined by a 50% reduction in the sleep SWI when comparing the post- and pre-treatment EEGs.